Grade III Prostatic Intraepithelial Neoplasia: High grade prostatic intraepithelial neoplasia characterized by the presence of severe architectural and cytologic abnormalities.
Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule
CD2_INSITU_PROSTATE
Extra metadata
List of similar endpoints to
Carcinoma in situ of prostate
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 16 | - | 16 |
| Unadjusted prevalence (%) | 0.01 | - | 0.01 |
| Mean age at first event (years) | 67.99 | - | 67.99 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | - | - | - | - |
| 15 years | - | - | - | - |
| 5 years | - | - | - | - |
| 1 year | - | - | - | - |
Index endpoint: CD2_INSITU_PROSTATE – Carcinoma in situ of prostate
GWS hits:
before Carcinoma in situ of prostate
after Carcinoma in situ of prostate
Loading survival analyses plot
Loading survival analyses table